DIGIPHARM ->

I would like to bring to your attention one very effective and interesting project. With it, you can change your future. Let's understand in more detail.

Digipharm brings together industry expertise, a mature concept and revolutionary blockchain technology to facilitate the transformation of healthcare to a value-based approach.

Spiralling healthcare costs combined with resource constraints have resulted in an unremitting burden on health systems. Trade-offs need to be made, patients are at risk of being denied innovative treatments and there remains barriers to reimbursement for manufacturers.

Digipharm bypasses infrastructural limitations to enable the implementation of flexible value-based pricing agreements using smart contracts, the development of unprecedented evidence platforms and the ability to reward patients for contributing their data.

Our Vision

To be the pioneer of sustainable and value-based healthcare delivery,
innovative evidence generation and patient empowerment across the healthcare industry.

The Future of Healthcare

Value Based Care

Healthcare systems around the world are currently threatened by challenges unique to our time; unsustainable expenditure, ageing populations and the increasing prevalence of chronic diseases. The concept of value based healthcare proposes that payment for healthcare should be tied to the quality of care and the benefits it provides; switching from a ‘fee for service’ to a ‘fee for performance’ reimbursement model.

Innovative Pricing

Innovative pricing solutions such as value-based pricing offer an increasingly dynamic solution to address the uncertainty around the cost of treatment relative to patient outcomes. Such mechanisms reward manufacturers and providers for improving patient outcomes, incentivise innovation and encourage the transition to patient centric healthcare.

Pioneering Evidence Generation

Innovative evidence generation solutions are necessary to satisfy the requirement of relevant, timely and quality data to inform the provision of optimised value based healthcare. Circumventing the use of static or retrospective data will open the horizon to superior forecasting, confidence in decision making and global oversight with regards to current developments in an increasingly dynamic industry such as healthcare.

The Digipharm Difference

Elimination of Barriers

Whilst value based healthcare provides the solution to numerous issues faced by healthcare systems, the extensive uptake of a value-based approach has been hindered by the infrastructural limitations of current health information systems, the administrative burden of its implementation and the fragmentation of health care delivery and patient outcomes data.

Patient Empowerment

Digipharm are strong believers in empowering patients with the custodianship and ownership of their personal data. Patients will be incentivised to share and contribute their health related data to inform decision making and health related research.

Blockchain Technology

Digipharms’ solutions will facilitate and accelerate the paradigm shift to value based and patient centric healthcare using ‘smart contracts’ and blockchain technology. Utilising blockchain technology for Digipharms’ platforms promotes the development of a decentralised health information infrastructure that is ubiquitous, transparent and security conscious.

Our Flagship Solutions

Reimburse will eliminate the infrastructural barriers and automate the implementation of value based pricing agreements, no matter how complex, on a fully independent global platform; encouraging personalised reimbursement of health technology on a ‘fee for performance’ basis for the mutual benefit of patients, payers and manufacturers.

Accelerates access to high cost therapy
Incentivises innovation
Drastically reduces administrative costs

Insights is the first ever ‘live’ real world evidence repository and allows the utilisation of real world evidence (RWE) as soon as it becomes available. The availability of ‘live’ RWE will provide stakeholders with real time intelligence with which they can inform decision making and product development across the medicinal lifecycle.

Incentives for patients to contribute data
Significant cost savings compared to conventional RWE sources
Single platform for global evidence

In anticipation of the challenges presented by integrating Digipharms’ platforms with existing IT infrastructure within national health systems or large primary care networks, agile API integration studies of such diverse and complex systems will be performed prior to the development of our bespoke integration engine. Where API integration with existing infrastructure is neither feasible or applicable; for example independent clinics, standalone applications will be developed. Our team is dedicated to facilitating the timely uptake of Digipharms’ solutions in real world settings and to help potential users embrace our platforms whilst minimising any adverse impact on existing infrastructure. Leveraging on an API driven development process will allow the development of user friendly interface to allow users to simply invoke smart contract transactions or query ledger data when required.

Since much of data transferred on Digipharm platforms is likely to be confidential for many platform participants, using permissioned blockchain technology will give members the power to conduct confidential transactions using private channels. For example, this would allow the safeguarding of confidential pricing information between manufacturers and payers (member peer nodes) where subjects can only join such channels subject to approval by all channel members. Digipharms’ fully independent platforms will all utilise confidentiality domains to conduct private data transactions over secure, cryptographically encrypted channels. Additionally, such technology can also allow global entities to operate local peers in multiple regions while still being part of the same blockchain network.

Our development team will also be focusing heavily on interoperability between alternative blockchain platforms, utilising an approach similar to ChainLink, allowing for integration of not only other blockchains, but Web APIs. As anticipated, the increased adoption of blockchain technology in the health industry e.g. decentralised medical records or payment systems, will require Digipharm platforms to support such eventualities.